On December 28, 2022 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, reported that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference (Press release, Guardant Health, DEC 28, 2022, View Source [SID1234625653]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guardant Health’s management is scheduled to present and participate in a Q&A session on Monday, January 9th at 3:00 p.m. Pacific Time / 6:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at: www.guardanthealth.com.